Try our Advanced Search for more refined results

GLAXOSMITHKLINE LLC v. TEVA PHARMACEUTICALS USA, INC.

  1. June 24, 2014

    GSK Blasts Teva's Use Of Pom Ruling To Nix False-Ad Suit

    GlaxoSmithKline LLC criticized Teva Pharmaceuticals USA Inc.'s request for reconsideration of a Pennsylvania federal judge's refusal to dismiss GSK's suit, which accuses Teva of falsely advertising a generic antidepressant as equivalent to Wellbutrin, arguing Tuesday that Teva misinterpreted Pom Wonderful.

  2. March 10, 2014

    Teva Can't Dodge GSK's Wellbutrin False Ad Suit

    A Pennsylvania federal judge refused Monday to dismiss GlaxoSmithKline LLC's lawsuit accusing Teva Pharmaceuticals USA Inc. of falsely advertising a generic antidepressant as equivalent to GSK's brand-name version, saying it was not preempted by a past U.S. Food and Drug Administration finding.

  3. February 11, 2013

    GSK Lobs False Ad Suit At Teva Over Axed Wellbutrin Generic

    GlaxoSmithKline LLC on Friday launched a false advertising suit in Pennsylvania federal court accusing Teva Pharmaceuticals USA Inc. of costing it hundreds of millions of dollars by promoting a generic version of antidepressant Wellbutrin that was discontinued after its effectiveness came into question.